CN111840505A - Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof - Google Patents

Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof Download PDF

Info

Publication number
CN111840505A
CN111840505A CN202010873499.2A CN202010873499A CN111840505A CN 111840505 A CN111840505 A CN 111840505A CN 202010873499 A CN202010873499 A CN 202010873499A CN 111840505 A CN111840505 A CN 111840505A
Authority
CN
China
Prior art keywords
parts
preparation
psoriasis
weight
following components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010873499.2A
Other languages
Chinese (zh)
Other versions
CN111840505B (en
Inventor
黄蜀
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010873499.2A priority Critical patent/CN111840505B/en
Publication of CN111840505A publication Critical patent/CN111840505A/en
Application granted granted Critical
Publication of CN111840505B publication Critical patent/CN111840505B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714Aconitum (monkshood)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • A61K36/195Strobilanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315Isatis, e.g. Dyer's woad
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535Perilla (beefsteak plant)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/58Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/84Valerianaceae (Valerian family), e.g. valerian
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9064Amomum, e.g. round cardamom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a traditional Chinese medicine preparation and plaster for treating psoriasis and a preparation method thereof, and relates to the technical field of medicines. Compared with the prior art, the invention adopts the method of treating both internal and external diseases and treating both principal and secondary aspect of disease, can shorten the treatment period of psoriasis, effectively control the psoriasis and enhance the long-term effect of psoriasis treatment; the oral preparation of the invention takes warming yang to transform qi into water, and attaches importance to yang qi of human body; the external preparation has the effects of dispelling wind, promoting diuresis, cooling blood, moistening dryness and promoting skin repair; the invention is compatible according to the prescription idea of the meridian formula, aims at the basic pathogenesis of psoriasis, is safe and effective, can obviously reduce the recurrence rate of psoriasis and recovers the barrier function of skin.

Description

Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof
Technical Field
The invention relates to the technical field of medicines, and particularly relates to a traditional Chinese medicine preparation and plaster for treating psoriasis and a preparation method thereof.
Background
Psoriasis is commonly called as psoriasis, is a chronic inflammatory skin disease, has long course of disease and easy recurrence tendency, and some cases are not cured almost for the whole life. The disease is mainly developed in young and old years, and has great influence on the physical health and mental conditions of patients. The clinical manifestations mainly include erythema and scales, all diseases occur in the whole body, the scalp and the limbs are common, and the disease is aggravated in winter. According to incomplete statistics, the number of patients is nearly 20000 thousands worldwide, 300 thousands of patients are still existed in China, and the incidence rate is still on the rising trend in recent years, wherein the incidence rate of the common type accounts for more than 95% of psoriasis, and the progress period is mainly. Because the pathogenesis of the psoriasis is unknown, the pathogenesis is complex, the cure rate is low, the psoriasis is easy to relapse, and the physical and mental health of a patient is seriously influenced.
Many psoriasis treatment methods are available, but most psoriasis treatment methods can only achieve the near-term clinical effect or temporarily relieve symptoms, and no good radical treatment method exists at present. Modern medicine advocates the simple use of topical medications for patients with mild to moderate psoriasis (usually psoriasis vulgaris with skin lesions of < 20% of body surface area), in view of the high rate of recurrence of psoriasis and the systemic adverse effects of oral medications. The psoriasis is treated by external drugs, and the western medicine mostly adopts corticosteroid hormone, tretinoin, calcipotriol, tar, anthralin, salicylic acid preparation and the like, and the drugs have large side effect, local stimulation or high price and cannot be used for a long time and a large area. The traditional external treatment prescription for the disease mostly contains heavy metal medicines, and is greatly inhibited on the safety of the external medicines.
At present, the psoriasis is clinically treated by using an anti-tumor drug, glucocorticoid, a retinoic acid drug, an immunotherapy and a biological preparation, and according to years of clinical research, the treatment methods can control skin lesions in a short period and delay the progress of the disease, but the pathogenesis of the psoriasis is not clear, related treatment targets are not clear, the psoriasis is easy to generate drug dependence after long-term use, the disease rebound phenomenon can occur once the psoriasis is reduced or stopped, meanwhile, the skin lesions can have local color deposition, pores and striae atrophy, the barrier function is damaged, and even fungal or bacterial infection is complicated, so that the disease is delayed and difficult to heal, and the life quality of patients is greatly influenced.
Disclosure of Invention
In order to solve the technical problems, the invention firstly aims to provide a traditional Chinese medicine preparation for treating psoriasis, which comprises an oral preparation and an external preparation, adopts a method of simultaneous treatment of internal and external application and treatment of both symptoms and root causes, and can improve the long-term clinical curative effect by comprehensive treatment.
The invention also aims to provide a plaster for treating psoriasis and a preparation method thereof.
In order to achieve the above object, the technical solution of the present invention is as follows.
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
5-10 parts of rhizoma typhonii slice, 5-10 parts of semen coicis, 5-10 parts of rhizoma smilacis glabrae, 5-10 parts of cassia twig, 5-10 parts of ginger, 5-10 parts of peach kernel, 5-10 parts of angelica sinensis, 5-10 parts of cortex phellodendri, 5-10 parts of herba patriniae, 5-10 parts of cortex moutan, 5-10 parts of fructus amomi, 5-10 parts of perilla leaf, 5-10 parts of herba schizonepetae and 5-10 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
5-10 parts of indigo naturalis, 5-10 parts of sulfur, 5-10 parts of rheum officinale, 5-10 parts of turmeric, 5-10 parts of golden cypress, 5-10 parts of garden burnet, 5-10 parts of chinaberry fruit, 5-10 parts of prepared kusnezoff monkshood root, 5-10 parts of mint, 1-3 parts of borneol, 5-10 parts of purslane, 5-10 parts of cortex moutan, 5-10 parts of Chinese angelica, 5-10 parts of red paeony root, 5-10 parts of cortex dictamni and 5-10 parts of rhizoma polygonati.
The traditional Chinese medicine preparation provided by the invention has the main effects of dispelling wind and promoting diuresis, warming yang and removing blood stasis, and protecting yang qi in a body. In the invention, the method of treating both internal and external diseases and treating both symptoms and root causes is adopted, and the traditional Chinese medicine is a self-prepared prescription. According to the theory of external treatment, i.e., the theory of internal treatment, and the theory of external treatment, i.e., the theory of internal treatment, in the Congregation, the ear is treated differently. The internal and external concurrent treatment is adopted, so that the psoriasis treatment period can be shortened, the psoriasis recovery can be effectively controlled, and the long-term effect of the psoriasis treatment can be enhanced; the oral preparation of the invention takes warming yang to transform qi into water, and attaches importance to yang qi of human body; the external preparation has the effects of dispelling wind, promoting diuresis, cooling blood, moistening dryness and promoting skin repair; the invention is compatible according to the prescription idea of the meridian formula, aims at the basic pathogenesis of psoriasis, is safe and effective, can obviously reduce the recurrence rate of psoriasis and recovers the barrier function of skin.
In the oral preparation, the rhizoma typhonii slices and the cinnamon branches warm yang and transform qi into water; herba Patriniae and cortex Phellodendri have effects of clearing away heat and toxic materials; the ginger, the perilla leaf and the schizonepeta are used for dispelling wind and relieving exterior syndrome; fructus Amomi is fragrant and turbid; radix Paeoniae Rubra, cortex moutan, semen Persicae, and radix Angelicae sinensis for cooling blood and removing blood stasis; coix seed and rhizoma smilacis glabrae have the effects of removing dampness by means of bland excreting;
in the external preparation, the turmeric, the sulfur and the prepared kusnezoff monkshood root are used for dispelling cold and eliminating dampness; indigo naturalis, rhubarb, phellodendron, chinaberry fruit, purslane and cortex dictamni are capable of clearing away heat and toxic materials, and modern researches prove that the heat-clearing and detoxifying drug has strong effects of inhibiting epidermal cell proliferation and resisting inflammation and inhibiting humoral immunity, and can promote skin lesions of patients with psoriasis to disappear and restore the color to normal. Rhizoma Polygonati, radix Angelicae sinensis, radix Paeoniae Rubra, cortex moutan, and radix Sangusorbae for cooling blood, promoting blood circulation and moistening dryness; herba Menthae and Borneolum Syntheticum has effects of dispelling pathogenic wind, relieving exterior syndrome, and relieving itching; wherein, the angelica enriches the blood and nourishes the yin, the red peony root promotes the blood circulation and removes the obstruction in the channels, and the stagnation in the blood is removed; the two medicines are used together, so that the effects of enriching and nourishing blood, increasing local blood supply, improving skin malnutrition, moistening skin, reducing scales and enhancing itching relieving are achieved.
Further, the oral preparation comprises the following components in parts by weight:
6 parts of rhizoma typhonii slice, 6 parts of semen coicis, 6 parts of rhizoma smilacis glabrae, 6 parts of cassia twig, 6 parts of ginger, 6 parts of peach kernel, 6 parts of angelica, 6 parts of cortex phellodendri, 6 parts of herba patriniae, 6 parts of cortex moutan, 6 parts of fructus amomi, 6 parts of perilla leaf, 6 parts of herba schizonepetae and 6 parts of radix paeoniae rubra.
Further, the oral preparation comprises the following components in parts by weight:
5 parts of rhizoma typhonii slice, 5 parts of semen coicis, 5 parts of rhizoma smilacis glabrae, 5 parts of cassia twig, 5 parts of ginger, 5 parts of peach kernel, 5 parts of angelica, 5 parts of phellodendron, 5 parts of herba patriniae, 5 parts of cortex moutan, 5 parts of fructus amomi, 5 parts of perilla leaf, 5 parts of herba schizonepetae and 5 parts of radix paeoniae rubra.
Further, the oral preparation comprises the following components in parts by weight:
10 parts of rhizoma typhonii slice, 10 parts of semen coicis, 10 parts of rhizoma smilacis glabrae, 10 parts of cassia twig, 10 parts of ginger, 10 parts of peach kernel, 10 parts of angelica, 10 parts of phellodendron, 10 parts of herba patriniae, 10 parts of cortex moutan, 10 parts of fructus amomi, 10 parts of perilla leaf, 10 parts of schizonepeta and 10 parts of radix paeoniae rubra.
Further, the external preparation also comprises the following components in parts by weight:
5-10 parts of dark plum and 5-10 parts of pearl powder.
Further, the external preparation comprises the following components in parts by weight:
6 parts of indigo naturalis, 6 parts of sulfur, 6 parts of rheum officinale, 6 parts of turmeric, 6 parts of golden cypress, 6 parts of garden burnet, 6 parts of chinaberry fruit, 6 parts of prepared kusnezoff monkshood root, 6 parts of mint, 1 part of borneol, 6 parts of purslane, 6 parts of cortex moutan, 6 parts of Chinese angelica, 6 parts of red paeony root, 6 parts of cortex dictamni, 6 parts of rhizoma polygonati, 6 parts of dark plum fruit and 6 parts of pearl powder.
Further, the external preparation comprises the following components in parts by weight:
5 parts of indigo naturalis, 5 parts of sulfur, 5 parts of rheum officinale, 5 parts of turmeric, 5 parts of golden cypress, 5 parts of garden burnet, 5 parts of chinaberry fruit, 5 parts of prepared kusnezoff monkshood root, 5 parts of mint, 1 part of borneol, 5 parts of purslane, 5 parts of cortex moutan, 5 parts of Chinese angelica, 5 parts of red paeony root, 5 parts of cortex dictamni, 5 parts of rhizoma polygonati, 5 parts of dark plum fruit and 5 parts of pearl powder.
Further, the external preparation comprises the following components in parts by weight:
10 parts of indigo naturalis, 10 parts of sulfur, 10 parts of rheum officinale, 10 parts of turmeric, 10 parts of golden cypress, 10 parts of garden burnet, 10 parts of chinaberry fruit, 10 parts of prepared kusnezoff monkshood root, 10 parts of mint, 3 parts of borneol, 10 parts of purslane, 10 parts of cortex moutan, 10 parts of Chinese angelica, 10 parts of red paeony root, 10 parts of cortex dictamni, 10 parts of rhizoma polygonati, 10 parts of dark plum fruit and 10 parts of pearl powder.
The invention also provides a plaster for treating psoriasis, which is prepared by adopting the external preparation of the traditional Chinese medicine preparation.
The invention also provides a preparation method of the plaster for treating psoriasis, which comprises the following steps:
processing the raw materials of the external preparation by superfine grinding technology, and sieving with No. 9 sieve to obtain superfine powder (more than 200 meshes); wherein the mineral, herba Menthae, HUANGJING and other viscous medicines are pulverized separately;
weighing the medicinal powder of each raw material according to the formula ratio, and filling the medicinal powder into a container to be uniformly mixed for later use;
40-60 parts by weight of vaseline is put into another container and heated to be melted for standby;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stopping heating after stirring uniformly, and cooling to obtain the plaster.
The invention has the beneficial effects that: compared with the prior art, the method has the advantages that,
(1) the invention adopts a method of treating both internal and external diseases and treating both principal and secondary aspect of disease, can shorten the treatment period of psoriasis, effectively control the psoriasis and enhance the long-term effect of psoriasis treatment.
(2) The oral preparation of the invention takes warming yang to transform qi into water, and attaches importance to yang qi of human body; the external preparation has the effects of dispelling wind, promoting diuresis, cooling blood, moistening dryness and promoting skin repair.
(3) The invention is compatible according to the prescription idea of the meridian formula, aims at the basic pathogenesis of psoriasis, is safe and effective, can obviously reduce the recurrence rate of psoriasis and recovers the barrier function of skin.
Detailed Description
The present invention will be described in further detail in order to make the objects, technical solutions and advantageous effects of the present invention more apparent. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
6 parts of rhizoma typhonii, 6 parts of semen coicis, 6 parts of rhizoma smilacis glabrae, 6 parts of cassia twig, 6 parts of ginger, 6 parts of peach kernel, 6 parts of angelica, 6 parts of phellodendron, 6 parts of herba patriniae, 6 parts of cortex moutan, 6 parts of fructus amomi, 6 parts of perilla leaf, 6 parts of herba schizonepetae and 6 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
6 parts of indigo naturalis, 6 parts of sulfur, 6 parts of rheum officinale, 6 parts of turmeric, 6 parts of golden cypress, 6 parts of garden burnet, 6 parts of chinaberry fruit, 6 parts of prepared kusnezoff monkshood root, 6 parts of mint, 1 part of borneol, 6 parts of purslane, 6 parts of cortex moutan, 6 parts of Chinese angelica, 6 parts of red paeony root, 6 parts of cortex dictamni, 6 parts of rhizoma polygonati, 6 parts of dark plum fruit and 6 parts of pearl powder.
Decocting the oral preparation in water for 2 hr, filtering, and collecting filtrate for oral administration;
weighing the raw materials of the external preparation according to the formula, separately crushing by an ultrafine crusher, sieving to obtain 1000-mesh medicinal powder, respectively filling into a sealed tank, and irradiating all the filled medicinal powder with cobalt 60 for sterilization;
putting the medicinal powder according to the formula amount into a 1000 ml container, and uniformly mixing the medicinal powder by using a stirring rod for later use;
50 parts by weight of vaseline is put into a 2000 ml stainless steel container and heated to be melted for 20 minutes at 300 ℃;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stirring for 10 min till uniformity, stopping heating, pouring into a split charging box while the mixture is hot, and cooling to obtain the plaster.
The using method comprises the following steps: the cooled plaster is directly applied to the skin lesion three times a day.
Example 2
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
5 parts of rhizoma typhonii slices, 5 parts of semen coicis, 5 parts of rhizoma smilacis glabrae, 5 parts of cassia twig, 5 parts of ginger, 5 parts of peach kernel, 5 parts of angelica, 5 parts of phellodendron, 5 parts of herba patriniae, 5 parts of cortex moutan, 5 parts of fructus amomi, 5 parts of perilla leaf, 5 parts of herba schizonepetae and 5 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
5 parts of indigo naturalis, 5 parts of sulfur, 5 parts of rheum officinale, 5 parts of turmeric, 5 parts of golden cypress, 5 parts of garden burnet, 5 parts of chinaberry fruit, 5 parts of prepared kusnezoff monkshood root, 5 parts of mint, 1 part of borneol, 5 parts of purslane, 5 parts of cortex moutan, 5 parts of Chinese angelica, 5 parts of red paeony root, 5 parts of cortex dictamni, 5 parts of rhizoma polygonati, 5 parts of dark plum fruit and 5 parts of pearl powder.
Decocting the oral preparation in water for 2 hr, filtering, and collecting filtrate for oral administration;
weighing the raw materials of the external preparation according to the formula, separately crushing by an ultrafine crusher, sieving to obtain 1000-mesh medicinal powder, respectively filling into a sealed tank, and irradiating all the filled medicinal powder with cobalt 60 for sterilization;
putting the medicinal powder according to the formula amount into a 1000 ml container, and uniformly mixing the medicinal powder by using a stirring rod for later use;
40 parts by weight of vaseline is put into a 2000 ml stainless steel container and heated to be melted for 20 minutes at 300 ℃;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stirring for 10 min till uniformity, stopping heating, pouring into a split charging box while the mixture is hot, and cooling to obtain the plaster.
The using method comprises the following steps: the cooled plaster is directly applied to the skin lesion three times a day.
Example 3
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
10 parts of rhizoma typhonii slices, 10 parts of semen coicis, 10 parts of rhizoma smilacis glabrae, 10 parts of cassia twig, 10 parts of ginger, 10 parts of peach kernel, 10 parts of angelica, 10 parts of phellodendron, 10 parts of herba patriniae, 10 parts of cortex moutan, 10 parts of fructus amomi, 10 parts of perilla leaf, 10 parts of schizonepeta and 10 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
10 parts of indigo naturalis, 10 parts of sulfur, 10 parts of rheum officinale, 10 parts of turmeric, 10 parts of golden cypress, 10 parts of garden burnet, 10 parts of chinaberry fruit, 10 parts of prepared kusnezoff monkshood root, 10 parts of mint, 3 parts of borneol, 10 parts of purslane, 10 parts of cortex moutan, 10 parts of Chinese angelica, 10 parts of red paeony root, 10 parts of cortex dictamni, 10 parts of rhizoma polygonati, 10 parts of dark plum fruit and 10 parts of pearl powder.
Decocting the oral preparation in water for 2 hr, filtering, and collecting filtrate for oral administration;
weighing the raw materials of the external preparation according to the formula, separately crushing by an ultrafine crusher, sieving to obtain 1000-mesh medicinal powder, respectively filling into a sealed tank, and irradiating all the filled medicinal powder with cobalt 60 for sterilization;
putting the medicinal powder according to the formula amount into a 1000 ml container, and uniformly mixing the medicinal powder by using a stirring rod for later use;
60 parts by weight of vaseline is put into a 2000 ml stainless steel container and heated to be melted for 20 minutes at 300 ℃;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stirring for 10 min till uniformity, stopping heating, pouring into a split charging box while the mixture is hot, and cooling to obtain the plaster.
The using method comprises the following steps: the cooled plaster is directly applied to the skin lesion three times a day.
Example 4
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
6 parts of rhizoma typhonii, 6 parts of semen coicis, 6 parts of rhizoma smilacis glabrae, 6 parts of cassia twig, 6 parts of ginger, 6 parts of peach kernel, 6 parts of angelica, 6 parts of phellodendron, 6 parts of herba patriniae, 6 parts of cortex moutan, 6 parts of fructus amomi, 6 parts of perilla leaf, 6 parts of herba schizonepetae and 6 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
6 parts of indigo naturalis, 6 parts of sulfur, 6 parts of rheum officinale, 6 parts of turmeric, 6 parts of golden cypress, 6 parts of garden burnet, 6 parts of chinaberry fruit, 6 parts of prepared kusnezoff monkshood root, 6 parts of mint, 1 part of borneol, 6 parts of purslane, 6 parts of cortex moutan, 6 parts of Chinese angelica, 6 parts of red paeony root, 6 parts of cortex dictamni and 6 parts of rhizoma polygonati.
Decocting the oral preparation in water for 2 hr, filtering, and collecting filtrate for oral administration;
weighing the raw materials of the external preparation according to the formula, separately crushing by an ultrafine crusher, sieving to obtain 1000-mesh medicinal powder, respectively filling into a sealed tank, and irradiating all the filled medicinal powder with cobalt 60 for sterilization;
putting the medicinal powder according to the formula amount into a 1000 ml container, and uniformly mixing the medicinal powder by using a stirring rod for later use;
50 parts by weight of vaseline is put into a 2000 ml stainless steel container and heated to be melted for 20 minutes at 300 ℃;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stirring for 10 min till uniformity, stopping heating, pouring into a split charging box while the mixture is hot, and cooling to obtain the plaster.
The using method comprises the following steps: the cooled plaster is directly applied to the skin lesion three times a day.
Example 5
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
8 parts of rhizoma typhonii slices, 8 parts of semen coicis, 8 parts of rhizoma smilacis glabrae, 8 parts of cassia twig, 8 parts of ginger, 8 parts of peach kernel, 8 parts of angelica, 8 parts of phellodendron, 8 parts of herba patriniae, 8 parts of cortex moutan, 8 parts of fructus amomi, 8 parts of perilla leaf, 8 parts of schizonepeta and 8 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
8 parts of indigo naturalis, 8 parts of sulfur, 8 parts of rheum officinale, 8 parts of turmeric, 8 parts of golden cypress, 8 parts of garden burnet, 8 parts of chinaberry fruit, 8 parts of prepared kusnezoff monkshood root, 8 parts of mint, 2 parts of borneol, 8 parts of purslane, 8 parts of cortex moutan, 8 parts of Chinese angelica, 8 parts of red paeony root, 8 parts of cortex dictamni, 8 parts of rhizoma polygonati, 8 parts of dark plum fruit and 8 parts of pearl powder.
Decocting the oral preparation in water for 2 hr, filtering, and collecting filtrate for oral administration;
weighing the raw materials of the external preparation according to the formula, separately crushing by an ultrafine crusher, sieving to obtain 1000-mesh medicinal powder, respectively filling into a sealed tank, and irradiating all the filled medicinal powder with cobalt 60 for sterilization;
putting the medicinal powder according to the formula amount into a 1000 ml container, and uniformly mixing the medicinal powder by using a stirring rod for later use;
50 parts by weight of vaseline is put into a 2000 ml stainless steel container and heated to be melted for 20 minutes at 300 ℃;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stirring for 10 min till uniformity, stopping heating, pouring into a split charging box while the mixture is hot, and cooling to obtain the plaster.
The using method comprises the following steps: the cooled plaster is directly applied to the skin lesion three times a day.
Example 6
A Chinese medicinal preparation for treating psoriasis comprises oral preparation and external preparation;
the oral preparation comprises the following components in parts by weight:
9 parts of rhizoma typhonii, 9 parts of semen coicis, 9 parts of rhizoma smilacis glabrae, 9 parts of cassia twig, 9 parts of ginger, 9 parts of peach kernel, 9 parts of angelica, 9 parts of phellodendron, 9 parts of herba patriniae, 9 parts of cortex moutan, 9 parts of fructus amomi, 9 parts of perilla leaf, 9 parts of herba schizonepetae and 9 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
9 parts of indigo naturalis, 9 parts of sulfur, 9 parts of rheum officinale, 9 parts of turmeric, 9 parts of golden cypress, 9 parts of garden burnet, 9 parts of chinaberry fruit, 9 parts of prepared kusnezoff monkshood root, 9 parts of mint, 2 parts of borneol, 9 parts of purslane, 9 parts of cortex moutan, 9 parts of Chinese angelica, 9 parts of red paeony root, 9 parts of cortex dictamni, 9 parts of rhizoma polygonati, 9 parts of dark plum fruit and 9 parts of pearl powder.
Decocting the oral preparation in water for 2 hr, filtering, and collecting filtrate for oral administration;
weighing the raw materials of the external preparation according to the formula, separately crushing by an ultrafine crusher, sieving to obtain 1000-mesh medicinal powder, respectively filling into a sealed tank, and irradiating all the filled medicinal powder with cobalt 60 for sterilization;
putting the medicinal powder according to the formula amount into a 1000 ml container, and uniformly mixing the medicinal powder by using a stirring rod for later use;
50 parts by weight of vaseline is put into a 2000 ml stainless steel container and heated to be melted for 20 minutes at 300 ℃;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stirring for 10 min till uniformity, stopping heating, pouring into a split charging box while the mixture is hot, and cooling to obtain the plaster.
The using method comprises the following steps: the cooled plaster is directly applied to the skin lesion three times a day.
In order to verify the treatment effect of the traditional Chinese medicine preparation for treating psoriasis, a single-center random control research method is adopted.
1. 100 subjects were divided into two groups (50 in each of the treatment and control groups) using a completely randomized protocol, all patients enrolled were numbered in the order of treatment, and a randomized assignment was generated using the existing SPSS software. The random dispensing protocol was hidden (enclosed in a sequence-coded, sealed, light-tight envelope) for dispensing therapy and registered.
2 case selection
2.1 Western diagnostic standards
Reference is made to clinical dermatology (edited by Zhao dialectic sciences, 3 rd edition of Jiangsu science and technology Press, 4 months 2001).
Diagnostic criteria for psoriasis vulgaris
i. The skin damage of the disease is gradually enlarged from red inflammatory papules and maculopapules, and the red maculopapules are fused into red spot sheets with different sizes, and are covered with a plurality of layers of silvery white scales, and a layer of bright film can be seen after the scales are scraped off, and spot bleeding can occur under the film.
The rash form can be in a spot shape, a coin shape, a map shape, a mixed shape and the like, but the boundary is obvious.
i i i. rashes can occur everywhere on the body surface. When the scalp occurs, the hair is in the shape of a bundle; the nail plate (finger, toe) may have a point-shaped concave part in the shape of a thimble or the nail plate may be uneven, yellow and thick.
Different degrees of itching may accompany it.
v. slow course of disease, easy recurrence.
(II) clinical staging criteria
i. The implementation period is as follows: acute onset, continuous appearance of new rash, continuous expansion of old rash, thick and accumulated scales, obvious inflammation and remarkable itching feeling, and homomorphic reaction can be seen.
Stationary phase (stationary phase): stable disease condition, temporary stop of development, reduced inflammation, no new eruption and no regression of old rash.
i i i. recovery period (retirement period): the skin lesion becomes thin and small, the color turns to be light, the inflammation basically disappears, the scale is obviously reduced until the skin lesion is faded, and the temporary pigmentation spots or depigmentation spots are left.
2.2 Chinese medicine syndrome diagnostic criteria
It is formulated according to the "standard of curative effect for diagnosing Chinese medicine diseases" (national institute of Chinese medicine and drug administration, Nanjing university Press, 1994).
Wind-heat and blood-dryness type
The main symptoms are: the skin lesions are bright red, the rash appears continuously, the erythema is increased, the scales are scraped off, a bright film can be seen, the blood is in a punctate state, and the isomorphic reaction can be seen.
The secondary symptoms include pruritus of different degrees, vexation, thirst, dry stool, yellow urine, red tongue, yellow or greasy tongue coating, and wiry, slippery or rapid pulse. .
② blood deficiency and wind dryness type
The main symptoms are that the skin is light in color, part of the skin is faded and scales are more.
The secondary symptoms are dry mouth, dry stool, pale red tongue with thin and white coating and thready and slow pulse. .
Skin type of stasis
The main symptoms are that the skin is damaged, fat and wet, the color is dark red, and the skin can not be withdrawn for a long time.
The secondary symptoms are purple dark tongue or ecchymosis, petechia, and unsmooth or thready and slow pulse.
Those with more than 2 items of the above major and minor symptoms can be diagnosed as the syndrome.
2.3 test case criteria
2.3.1 case inclusion criteria
The medicine meets the traditional Chinese medicine diagnosis standard of wind-heat and blood dryness type psoriasis and the Western medicine diagnosis standard for ordinary psoriasis patients.
② the area of skin damage is less than 20 percent.
Age 18-60 years old, male and female are unlimited, women with fertility are not prepared for pregnancy during the test period and within one year after the test is finished.
Subjects had to voluntarily attend the study and comply with the study regulations, understand and comply with the follow-up schedule, and sign informed consent.
Within about one month, glucocorticoid, immunosuppressant and tretinoin preparation are not applied systematically; photochemotherapy and other topical treatments were not used for 2 weeks.
2.3.2 exclusion criteria
Those not meeting the inclusion standard.
② the case with exudation, erosion or ulcer of skin.
③ psoriasis of joint type, pustule type and erythroderma type.
Fourthly, other medicines which can influence the state of the psoriasis are used at the same time.
Fifth, for allergic patients.
Sixthly, the patient with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hemopoietic system and the like and the patient with mental disease are combined.
Seventhly, pregnant women and women in lactation.
2.3.3 cases of rejection and shedding
The patients who are wrongly taken in the case that the standard is not met or the cases which are not treated as required after the standard is met are eliminated.
② the patients with incomplete data will influence the curative effect or safety judgment.
And thirdly, the patient who can not insist on treatment due to the occurrence of accidents in the treatment process.
Patients who are not matched with the therapy in the treatment process.
Fifthly, the rejection rate and the falling rate are less than 20 percent.
3 methods of treatment
3.1 treatment group
A plaster prepared from the external preparation of example 1 of the present invention.
The method comprises the following steps: cleaning skin, and applying the plaster to affected part half an hour before sleep every night with an average application of 0.1g/cm 2.
The course of treatment is as follows: the medicine is continuously taken for 4 weeks, and the treatment is repeated for 1, 2, 3 and 4 weeks.
3.2 control group
Tazarotene (trade name: Leshi, manufactured by Chongqing Huabang pharmaceutical Co., Ltd.)
The method comprises the following steps: cleaning skin, and applying tamalodine to affected part twice a night before sleep with an average application of 0.1g/cm 2.
The course of treatment is as follows: the same treatment groups are used.
4 index Observation
4.1 Security Observation
4.1.1 demographic data: including age (range), sex, race, height, weight, health history, medication history, allergy history, medical history, etc.
4.1.2 general physical examination: such as respiration, heart rate, blood pressure, pulse, etc.
4.1.3 adverse reaction indexes: refer to the guidelines for research on new Chinese drugs (pharmacy, pharmacology, toxicology), observe skin irritation around skin lesions, and observe whether the affected area has pigmentation, bleeding spots, rough skin or thin skin.
4.1.4 Effect index
And (3) integral observation of skin damage: referring to' clinical guidelines (trial) for new Chinese medicine.
(1) Form of rash
Degree of scale: 0 minute: no scale is left; and 2, dividing: scales are visible; and 4, dividing: the scale is thick; 6 min: scale accumulation;
erythema: 0 point is no erythema; 2, the erythema is light or dark; 4, red skin damage; 6, fresh red skin lesions;
the infiltration thickening is 0 min, no infiltration thickening; 2, slightly higher than the surface of the skin, and unobvious appearance; 4, obviously higher than the surface, and moderately soaks the hardness when touching; medium hypertrophic or lichenified in 6 points.
(2) The degree of pruritus is 0, namely no pruritus exists; 2 points of occasional pruritus without affecting, working, learning and living; 4, paroxysmal pruritus, which is mild, heavy and affects sleep, work, study and life; 6 points of severe pruritus which seriously affects sleep, work, study and life
(3) Area of rash: (the area of a single palm occupies 1% of the body surface area when the five fingers of the patient are closed, estimated by the burned palm scoring method).
0 minute: no skin damage; and 5, dividing: the skin damage range accounts for less than or equal to 1 percent of the total surface area of the body; 10 min: the skin damage range accounts for more than 1% and less than or equal to 5% of the total surface area; 15 min: the skin damage range accounts for more than 5% of the total body surface area.
4.2 Observation time
Before treatment, 1, 2, 3, 4 weeks after treatment.
5 follow-up visit
Follow-up visits were made 1 time each at 1 and 3 months after the treatment was completed, and follow-up visits were made by means of a follow-up visit or telephone. And (5) observing the cure rate and the recurrence rate of the cases with obvious effects.
6 clinical evaluation
6.1 Effect evaluation
6.1.1 Observation of skin lesion score
6.1.2 evaluation of comprehensive therapeutic Effect
The comprehensive curative effect is judged according to the change of the skin damage score, and a 4-grade curative effect judgment standard is specially formulated according to the clinical guidelines (trial) for new traditional Chinese medicines in 2002 edition. The calculation formula (nimodipine method) is: [ (pre-treatment integral-post-treatment integral) ÷ pre-treatment integral ] × 100%, detailed below.
The clinical recovery: the skin lesions are completely removed, the symptoms disappear, and the integral value is reduced by more than or equal to 95 percent.
Secondly, effect is displayed: the skin lesions mostly disappear, the symptoms are obviously relieved, and the integral value is reduced by more than or equal to 70 percent by 95 percent.
③ effective: the lesions partially resolved and symptoms improved, with a 70% score reduction of > 50%.
Fourthly, invalidation: the regression of the skin lesions was not evident, and the symptoms were not reduced or worsened adversely: the integral value decreases by less than 50%.
Eligible subjects were randomized into treatment (50) and control (50) groups, and the gender distribution of the patients in both groups is shown in table 1:
TABLE 1 gender profiles of two groups of patients
Figure BDA0002651880960000141
The chi-square test shows that the P value is greater than 0.05, which indicates that the two groups of samples have no significant difference.
The age and disease course of the two groups are shown in table 2:
TABLE 2 comparison of age and course of disease (X. + -. S) between the treatment and control groups
Figure BDA0002651880960000142
After statistical treatment and non-parameter (M-W) test of two independent samples, the comparison P value between each index group is more than 0.05, which indicates that two groups of samples have no significant difference.
Comparison of the values of the PASI scores of the two groups before treatment is shown in Table 3
TABLE 3 comparison of the pre-treatment PASI scores (X. + -. S) for the treatment and control groups
Figure BDA0002651880960000151
After statistical treatment and nonparametric (M-W) test of two independent samples, the P value is greater than 0.05, which indicates that the two groups of samples have no significant difference.
The traditional Chinese medicine preparation for treating psoriasis and the tazarotene (produced by Chongqing Huabang pharmaceutical Co., Ltd.) are respectively administered for treatment. The treatment effect is observed by repeated diagnosis at weeks 1, 2, 3 and 4 after 4 weeks of continuous administration. The treatment group specifically used the plaster prepared from the external preparation of example 1 of the present invention, and the external plaster was directly applied to the skin lesion.
The results are shown in Table 4:
TABLE 4 comparison of the overall efficacy of the treatment groups and the control groups after treatment (50 cases) (%)
Figure BDA0002651880960000152
Comparative analysis of clinical efficacy after treatment in two groups of patients: the effective rate of the treatment group is 86.00%, the effective rate of the control group is 68.00%, and P is less than 0.05, which shows that the traditional Chinese medicine preparation is superior to 0.1% tazarotene cream for external use in treating common plaque psoriasis, and the curative effects of the two groups are statistically different.
Therefore, the experiments prove that the plaster prepared by adopting the formula of the external preparation has better curative effect compared with the existing external application product.
Furthermore, the curative effect of the traditional Chinese medicine prescription for treating psoriasis is compared with that of the traditional Chinese medicine preparation of the invention, and long-term clinical observation shows that the psoriasis is easy to recur in the later period when the traditional Chinese medicine prescription is used for treating psoriasis; by adopting the traditional Chinese medicine preparation of the embodiment 1 of the invention, the oral preparation and the external preparation are used together, and the traditional Chinese medicine preparation has definite curative effect and good safety and does not have adverse reaction and side effect when being used clinically for 13 years.
This is because the existing prescription treatment focuses on cooling blood, and scutellaria baicalensis and dried rehmannia root are generally selected to clear heat and cool blood, but in most patients with psoriasis, due to changes of diet and living style, such as overeating, uncooked, sleeping late and staying up all night, yang qi of spleen and kidney of human body can be injured, cold-dampness can be generated in the spleen and kidney, and cold-dampness can be generated in the body. The facial heat manifestations of some patients are due to the transformation of internal cold-dampness into heat, and the appearance of true cold with false heat syndrome due to external wind-evil. At the moment, the idea of clearing heat and cooling blood is taken as a prescription, so that yang qi of a patient is easy to further hurt, in addition, the defect of cold and cool retention of blood stasis is easy to cause, and the skin of the face is dark red in the later period.
Although the existing prescription is compatible with blood-activating medicines, under the condition of yang qi deficiency in vivo, the blood-activating efficacy of the traditional prescription is necessarily greatly reduced by the application of cold medicines, and the fundamental contradiction of low in-vivo warming and dredging functions is not solved, which is one of the important factors for easy relapse in the later stage of psoriasis. In addition, some patients with spleen deficiency, and wind, cold, dampness and heat can block qi movement of the body and affect the metabolism of body fluids, so edema, red swelling, even blisters, erosion of fluid and the like can appear on the face. The basic pathogenesis of the disease is that yin is blocked inside, yang is marked on the exterior or upper, and wind evil is attacked outside. Therefore, the existing prescription lacks the thought of warming yang, has insufficient efficacy of excreting dampness and invigorating spleen, and has the disadvantages of cooling blood and retaining stasis.
The traditional Chinese medicine preparation of the invention mainly has the functions of dispelling wind and promoting diuresis, warming yang and removing blood stasis, and protecting yang qi in the body. In the oral preparation, the rhizoma Typhonii and the ramulus Cinnamomi have the effects of warming yang, resolving qi and promoting diuresis; herba Patriniae and cortex Phellodendri have effects of clearing away heat and toxic materials; the ginger, the perilla leaf and the schizonepeta are used for dispelling wind and relieving exterior syndrome; fructus Amomi is fragrant and turbid; radix Paeoniae Rubra, cortex moutan, semen Persicae, and radix Angelicae sinensis for cooling blood and removing blood stasis; coix seed, semen Coicis and rhizoma Smilacis Glabrae have the effects of inducing diuresis.
In the external preparation, the turmeric, the sulfur and the prepared kusnezoff monkshood root are used for dispelling cold and eliminating dampness; indigo naturalis, rhubarb, phellodendron, chinaberry fruit, purslane and cortex dictamni are capable of clearing away heat and toxic materials, and modern researches prove that the heat-clearing and detoxifying drug has strong effects of inhibiting epidermal cell proliferation and resisting inflammation and inhibiting humoral immunity, and can promote skin lesions of patients with psoriasis to disappear and restore the color to normal.
In addition, rhizoma Polygonati, radix Angelicae sinensis, radix Paeoniae Rubra, cortex moutan, and radix Sangusorbae have effects of cooling blood, promoting blood circulation and moistening dryness; herba Menthae and Borneolum Syntheticum has effects of dispelling pathogenic wind, relieving exterior syndrome, and relieving itching; wherein, the angelica enriches the blood and nourishes the yin, the red peony root promotes the blood circulation and removes the obstruction in the channels, and the stagnation in the blood is removed; the combination of the two medicines can enrich and nourish blood, increase local blood supply, improve skin malnutrition, moisten skin, reduce scales and strengthen the efficacy of relieving itching, and is obviously superior to the prior prescription in the aspects of relieving local red swelling and hot pain, pruritus, subcutaneous edema and the like of psoriasis of a patient.
In addition, considering that the skin diseases can easily cause emotional anxiety of patients, in order to realize better treatment effect, the invention selects the dark plum and the angelica to nourish the liver and soften the liver, calm the liver and relieve depression. The pearl powder is selected to remove freckles, whiten skin and promote skin damage repair.
The present invention is not limited to the above preferred embodiments, and any modifications, equivalent replacements, and improvements made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (10)

1. A Chinese medicinal preparation for treating psoriasis is characterized by comprising an oral preparation and an external preparation;
the oral preparation comprises the following components in parts by weight:
5-10 parts of rhizoma typhonii slice, 5-10 parts of semen coicis, 5-10 parts of rhizoma smilacis glabrae, 5-10 parts of cassia twig, 5-10 parts of ginger, 5-10 parts of peach kernel, 5-10 parts of angelica sinensis, 5-10 parts of cortex phellodendri, 5-10 parts of herba patriniae, 5-10 parts of cortex moutan, 5-10 parts of fructus amomi, 5-10 parts of perilla leaf, 5-10 parts of herba schizonepetae and 5-10 parts of radix paeoniae rubra;
the external preparation comprises the following components in parts by weight:
5-10 parts of indigo naturalis, 5-10 parts of sulfur, 5-10 parts of rheum officinale, 5-10 parts of turmeric, 5-10 parts of golden cypress, 5-10 parts of garden burnet, 5-10 parts of chinaberry fruit, 5-10 parts of prepared kusnezoff monkshood root, 5-10 parts of mint, 1-3 parts of borneol, 5-10 parts of purslane, 5-10 parts of cortex moutan, 5-10 parts of Chinese angelica, 5-10 parts of red paeony root, 5-10 parts of cortex dictamni and 5-10 parts of rhizoma polygonati.
2. The traditional Chinese medicine preparation for treating psoriasis according to claim 1, wherein the oral preparation comprises the following components in parts by weight:
6 parts of rhizoma typhonii slice, 6 parts of semen coicis, 6 parts of rhizoma smilacis glabrae, 6 parts of cassia twig, 6 parts of ginger, 6 parts of peach kernel, 6 parts of angelica, 6 parts of cortex phellodendri, 6 parts of herba patriniae, 6 parts of cortex moutan, 6 parts of fructus amomi, 6 parts of perilla leaf, 6 parts of herba schizonepetae and 6 parts of radix paeoniae rubra.
3. The traditional Chinese medicine preparation for treating psoriasis according to claim 1, wherein the oral preparation comprises the following components in parts by weight:
5 parts of rhizoma typhonii slice, 5 parts of semen coicis, 5 parts of rhizoma smilacis glabrae, 5 parts of cassia twig, 5 parts of ginger, 5 parts of peach kernel, 5 parts of angelica, 5 parts of phellodendron, 5 parts of herba patriniae, 5 parts of cortex moutan, 5 parts of fructus amomi, 5 parts of perilla leaf, 5 parts of herba schizonepetae and 5 parts of radix paeoniae rubra.
4. The traditional Chinese medicine preparation for treating psoriasis according to claim 1, wherein the oral preparation comprises the following components in parts by weight:
10 parts of rhizoma typhonii slice, 10 parts of semen coicis, 10 parts of rhizoma smilacis glabrae, 10 parts of cassia twig, 10 parts of ginger, 10 parts of peach kernel, 10 parts of angelica, 10 parts of phellodendron, 10 parts of herba patriniae, 10 parts of cortex moutan, 10 parts of fructus amomi, 10 parts of perilla leaf, 10 parts of schizonepeta and 10 parts of radix paeoniae rubra.
5. The traditional Chinese medicine preparation for treating psoriasis according to claim 1, wherein the external preparation further comprises the following components in parts by weight:
5-10 parts of dark plum and 5-10 parts of pearl powder.
6. The traditional Chinese medicine preparation for treating psoriasis according to claim 5, wherein the external preparation further comprises the following components in parts by weight:
6 parts of indigo naturalis, 6 parts of sulfur, 6 parts of rheum officinale, 6 parts of turmeric, 6 parts of golden cypress, 6 parts of garden burnet, 6 parts of chinaberry fruit, 6 parts of prepared kusnezoff monkshood root, 6 parts of mint, 1 part of borneol, 6 parts of purslane, 6 parts of cortex moutan, 6 parts of Chinese angelica, 6 parts of red paeony root, 6 parts of cortex dictamni, 6 parts of rhizoma polygonati, 6 parts of dark plum fruit and 6 parts of pearl powder.
7. The traditional Chinese medicine preparation for treating psoriasis according to claim 5, wherein the external preparation further comprises the following components in parts by weight:
5 parts of indigo naturalis, 5 parts of sulfur, 5 parts of rheum officinale, 5 parts of turmeric, 5 parts of golden cypress, 5 parts of garden burnet, 5 parts of chinaberry fruit, 5 parts of prepared kusnezoff monkshood root, 5 parts of mint, 1 part of borneol, 5 parts of purslane, 5 parts of cortex moutan, 5 parts of Chinese angelica, 5 parts of red paeony root, 5 parts of cortex dictamni, 5 parts of rhizoma polygonati, 5 parts of dark plum fruit and 5 parts of pearl powder.
8. The traditional Chinese medicine preparation for treating psoriasis according to claim 5, wherein the external preparation further comprises the following components in parts by weight:
10 parts of indigo naturalis, 10 parts of sulfur, 10 parts of rheum officinale, 10 parts of turmeric, 10 parts of golden cypress, 10 parts of garden burnet, 10 parts of chinaberry fruit, 10 parts of prepared kusnezoff monkshood root, 10 parts of mint, 3 parts of borneol, 10 parts of purslane, 10 parts of cortex moutan, 10 parts of Chinese angelica, 10 parts of red paeony root, 10 parts of cortex dictamni, 10 parts of rhizoma polygonati, 10 parts of dark plum fruit and 10 parts of pearl powder.
9. A plaster for the treatment of psoriasis, characterized in that it is prepared by using the external preparation of the Chinese medicinal preparation of any one of claims 1 to 8.
10. A process for preparing a plaster for the treatment of psoriasis as claimed in claim 9, which comprises:
separately pulverizing each raw material of the external preparation according to any one of claims 1 to 8 and sieving to obtain medicinal powder;
weighing the medicinal powder of each raw material according to the formula ratio, and filling the medicinal powder into a container to be uniformly mixed for later use;
40-60 parts by weight of vaseline is put into another container and heated to be melted for standby;
pouring the uniformly mixed medicinal powder into vaseline solution, stirring and heating, stopping heating after stirring uniformly, and cooling to obtain the plaster.
CN202010873499.2A 2020-08-26 2020-08-26 Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof Active CN111840505B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010873499.2A CN111840505B (en) 2020-08-26 2020-08-26 Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010873499.2A CN111840505B (en) 2020-08-26 2020-08-26 Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof

Publications (2)

Publication Number Publication Date
CN111840505A true CN111840505A (en) 2020-10-30
CN111840505B CN111840505B (en) 2022-01-04

Family

ID=72967991

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010873499.2A Active CN111840505B (en) 2020-08-26 2020-08-26 Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111840505B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114129627A (en) * 2021-07-23 2022-03-04 南方医科大学皮肤病医院 Composition ointment for treating psoriasis, medical cap product and application of composition ointment
CN117064979A (en) * 2023-08-02 2023-11-17 中南民族大学 External skin care oil for preventing and treating psoriasis and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
万娟等: ""黄蜀运用温阳化瘀法治疗静止期银屑病经验"", 《湖南中医杂志》 *
刘群英等: ""白疕软膏治疗银屑病的实验研究"", 《广西医科大学学报》 *
童丹丹: ""黛硫膏治疗进行期寻常型银屑病70例观察"", 《实用中医药杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114129627A (en) * 2021-07-23 2022-03-04 南方医科大学皮肤病医院 Composition ointment for treating psoriasis, medical cap product and application of composition ointment
CN117064979A (en) * 2023-08-02 2023-11-17 中南民族大学 External skin care oil for preventing and treating psoriasis and preparation method and application thereof

Also Published As

Publication number Publication date
CN111840505B (en) 2022-01-04

Similar Documents

Publication Publication Date Title
CN111840505B (en) Traditional Chinese medicine preparation and plaster for treating psoriasis and preparation method thereof
CN103446261A (en) Chinese medicinal composition used for preventing and/or treating related skin lesion in tumour treatment
CN106728898A (en) A kind of pharmaceutical composition for repairing skin barrier and preparation method thereof
CN105213557A (en) A kind of Chinese medicine composition for the treatment of eczema
CN106728168B (en) A Chinese medicinal external preparation for treating eczema and psoriasis, and its preparation method
CN115054662A (en) A Chinese medicinal composition for treating dermatoses, and its preparation method
CN103212037A (en) Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine
CN105343847A (en) Traditional Chinese medicine composition for treating eczema containing folium artemisiae argyi and preparing method thereof
CN107617081B (en) Traditional Chinese medicine composition for treating alopecia and preparation method thereof
CN108403869B (en) Traditional Chinese medicine composition for removing chloasma and preparation method thereof
CN106177508A (en) The Chinese medicine external ointment for the treatment of radioactive skin injury
CN102727668B (en) Chinese medicine composition with effect of alleviating asthenopia and preparation method thereof
CN110585277A (en) Application of angelica sinensis asarum liquid medicament in preparation of medicament for treating chronic eczema
CN105168503B (en) It is a kind of to be used to prevent external medicine composition of radiodermatitis and preparation method thereof
CN112675264B (en) Composition for treating psoriasis, preparation method and application thereof
CN103169776A (en) External medicament for treating leucoderma and preparation method thereof
CN116650609B (en) Kidney-reinforcing and embryo-culturing medicament and preparation method thereof
CN108938757B (en) Medicine for treating acne and its preparing method
CN114848789B (en) Pain-relieving wheat grain moxibustion medium and preparation method thereof
CN112704702B (en) Traditional Chinese medicine composition for treating scalp psoriasis and preparation method thereof
CN105012821B (en) A kind of external medicine composition that sterilizing and itch-relieving is clearing heat and detoxicating and preparation method thereof and purposes
CN115137796A (en) Traditional Chinese medicine composition and traditional Chinese medicine pill for treating psoriasis and preparation method thereof
CN115154533A (en) Traditional Chinese medicine composition for treating chloasma as well as preparation method and application thereof
CN106266458B (en) A Chinese medicinal composition for treating psoriasis and neurodermatitis, and its application
CN117298238A (en) Traditional Chinese medicine composition for treating psoriasis and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant